{"version":"1.0","type":"link","title":"HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors.","author_name":"Powles T 외","author_url":"https://prs-insight.online/author/Powles%20T","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/124149","thumbnail_width":1200,"thumbnail_height":630}